CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-29 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −1,809 | $62.44 | $113K | 51,353 |
| 2025-12-22 | Blum Robert I President & CEO | Grant or award | +5,765 | 396,774 | ||
| 2025-12-22 | Blum Robert I President & CEO | Grant or award | +5,765 | 402,539 | ||
| 2025-12-22 | Blum Robert I President & CEO | Shares withheld for taxes | −2,935 | $62.72 | $184K | 399,604 |
| 2025-12-22 | Malik Fady Ibraham EVP Research & Development | Grant or award | +2,000 | 140,552 | ||
| 2025-12-22 | Malik Fady Ibraham EVP Research & Development | Grant or award | +2,000 | 142,552 | ||
| 2025-12-22 | Malik Fady Ibraham EVP Research & Development | Shares withheld for taxes | −1,016 | $62.72 | $64K | 141,536 |
| 2025-12-22 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +1,589 | 52,249 | ||
| 2025-12-22 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +1,588 | 53,837 | ||
| 2025-12-22 | Callos Andrew EVP, Chief Commercial Officer | Shares withheld for taxes | −675 | $62.72 | $42K | 53,162 |
| 2025-12-22 | Lee Sung EVP, Chief Financial Officer | Grant or award | +2,152 | 70,069 | ||
| 2025-12-22 | Lee Sung EVP, Chief Financial Officer | Grant or award | +2,152 | 72,221 | ||
| 2025-12-22 | Lee Sung EVP, Chief Financial Officer | Shares withheld for taxes | −805 | $62.72 | $50K | 71,416 |
| 2025-12-22 | Blum Robert I President & CEO | Option exercise | +54,727 | $6.67 | $365K | 404,929 |
| 2025-12-22 | Blum Robert I President & CEO | Shares withheld for taxes | −30,426 | $68.18 | $2.1M | 374,503 |
| 2025-12-22 | Blum Robert I President & CEO | Option exercise | +16,506 | $6.67 | $110K | 391,009 |
| 2025-12-22 | Blum Robert I President & CEO | Option exercise · Non-Qualified Stock Option (Right to Buy) | −54,727 | 0 | ||
| 2025-12-22 | Blum Robert I President & CEO | Option exercise · Incentive Stock Option (Right to Buy) | −16,506 | 0 | ||
| 2025-12-22 | WIERENGA WENDELL Director | Option exercise 10b5-1 | +20,000 | $7.61 | $152K | 52,444 |
| 2025-12-22 | WIERENGA WENDELL Director | Sale 10b5-1 | −20,000 | $66.14 | $1.3M | 32,444 |
Page 13 of 22 · 429 trades